Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001927

CERILLIANT™ Rufinamide Solution, 1.0 mg/mL in Acetonitrile:Water (9:1), Sold by MilliporeSigma™ Supelco™

Certified reference material

Supplier:  MilliporeSigma Supelco R0231ML

Catalog No. 01-001-927


Explore available promotions
Add to Cart

Description

Description

An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel™ in the US and Inovelon™ in the EU.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

75-05-8, 106308-44-5
UN 1648 3 / PGII
238.19
1 mL
C10H8F2N4O
1.0 mg/mL in acetonitrile:water (9:1)
Ampule
2°C (35.6°F) - closed cup
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

H332-H319

Recommended Storage : -20°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.

CERILLIANT is a registered trademark of Cerilliant Corporation